Advertisement

Topics

Orbus Pharma Incorporated Company Profile

07:42 EST 24th January 2019 | BioPortfolio

We are in process of listing on exchange and have a promising future in cephalosporin biotech.

Location

221 Shearson Crescent
Cambridge
Ontario
N1T 1J5
Canada

Contact

Phone: (905) 791 4866
Fax: (905) 791 2388
Email: jrenwick@orbus.ca


News Articles [427 Associated News Articles listed on BioPortfolio]

Orbus Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryOrbus Therapeutics Inc Orbus Therapeutics is a drug developer that offers development and commercialization of drugs for the treatment of anaplastic astrocytoma. The company develops eflornithi...

Orbus Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 10052018] Prices from USD $250

SummaryOrbus Therapeutics Inc Orbus Therapeutics is a drug developer that offers development and commercialization of drugs for the treatment of anaplastic astrocytoma. The company develops eflornithi...

CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease 

Itanapraced blocks LRRK2 expression and LRRK2-mediated neurotoxicity Itanapraced ready to advance to Phase 2 in Parkinson’s disease patients with and without genetic mutation NEW YORK and SINGAPO...

Deals and M&As this week: LEO Pharma, Valeo Pharma, Allergan

LEO Pharma and MorphoSys have formed a strategic partnership to develop peptide-derived therapeutics. LEO Pharma will select lead molecules using...Read More... The post Deals and M&As this week:...

M&As this week: Sun Pharma, Genentech, CVS Health

Sun Pharma has signed a definitive agreement to acquire Pola Pharma for $1m. The acquisition is part of Sun Pharma’s...Read More... The post M&As this week: Sun Pharma, Genentech, CVS Health ap...

EQT offers to buy Karo Pharma for $654m

Karo Pharma develops and markets products for pharmacies and also directly to the healthcare sector. The specialty pharma company is said to have a strong presence in the The post EQT offers to buy K...

More pharma cos sign MoUs with MADC to set up bulk drugs park in MIHAN, Nagpur

Following execution of MoUs with pharma companies─ Centaur, SG Pharma, Arco Lifesciences, BDH Pharma, Maharashtra Airport Development Company Ltd (MADC) has recently inked MoUs with pharma companies

Deals this week: Zealand Pharma, Fulcrum Therapeutics, Forendo Pharma

Zealand Pharma has sold its future royalty streams and potential commercial milestones for Soliqua® 100/33/Suliqua® and Lyxumia®/Adlyxin® to Royalty Pharma...Read More... The post Deals this week:...

Drugs and Medications [66 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Mayne Pharma Inc]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Mayne Pharma Inc]

Fluoride Chewable Tablets 1 mg

Urea [Mayne Pharma Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

NA

Ribavirin [Aurobindo Pharma Limited]

NA

PubMed Articles [23 Associated PubMed Articles listed on BioPortfolio]

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Clinical trials go virtual, big pharma dives in.

Disease awareness advertising (DAA) in emerging economy: A comparison between views of consumers and pharmaceutical professionals.

Research on effectiveness of DAA is limited. Existing researches explore impact of DAA only on relationship between drug manufacturers and consumers. However, in reality, pharma marketing revolves aro...

21 Century Citizen Pharma: The FDA & Patient-Focused Product Development.

Perpetual debate regarding the delicate balance between access and innovation and the protection of the public health and safety dominate discussions of the United States Food and Drug Administration ...

CVS and the $100,000 QALY.

The PBM unit of the health giant CVS decided that any new drug exceeding $100,000 per quality-adjusted life year (QALY) may be excluded from the formularies that are maintained by its clients. Patient...

Clinical Trials [86 Associated Clinical Trials listed on BioPortfolio]

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition

The primary objective is to determine clinical bioequivalence of Amphotericin B liposome for injection of Auromedics Pharma LLC, USA and AmBisome (Amphotericin B) liposome for injection of...

Companies [827 Associated Companies listed on BioPortfolio]

Orbus Pharma Incorporated

We are in process of listing on exchange and have a promising future in cephalosporin biotech.

Orbus Life Sciences Inc

Orbus is a pharmaceutical business that has been in operation since February 1, 2000. Orbus began as a trading business in fine chemicals and continues to operate this business today. Orbus owns a 10,...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

More Information about "Orbus Pharma Incorporated" on BioPortfolio

We have published hundreds of Orbus Pharma Incorporated news stories on BioPortfolio along with dozens of Orbus Pharma Incorporated Clinical Trials and PubMed Articles about Orbus Pharma Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Orbus Pharma Incorporated Companies in our database. You can also find out about relevant Orbus Pharma Incorporated Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record